Cargando…
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection
The recent global pandemic created by the Coronavirus SARS-CoV-2, started in Wuhan, China in December 2019, has generated panic, both in term of human death (4–5% of infected patients identified through testing) and the global economy. Human sufferings seem to be continuing, and it is not clear how...
Autor principal: | Ahmad, Shamim I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194918/ https://www.ncbi.nlm.nih.gov/pubmed/32438240 http://dx.doi.org/10.1016/j.mehy.2020.109754 |
Ejemplares similares
-
An Investigation of 2′-Deoxyribonucleoside Cyanoboranes in Mice for
Therapeutic Safety
por: Hall, Iris H., et al.
Publicado: (1994) -
Epimeric 2-Deoxyribose
Lesions: Products from
the Improper Chemical Repair of 2-Deoxyribose Radicals
por: Amato, Nicholas J., et al.
Publicado: (2014) -
Salvage of the 5-deoxyribose byproduct of radical SAM enzymes
por: Beaudoin, Guillaume A. W., et al.
Publicado: (2018) -
Oxidative Pathways of Deoxyribose and Deoxyribonate Catabolism
por: Price, Morgan N., et al.
Publicado: (2019) -
Studies on Transcriptional Incorporation of 5’-N-Triphosphates of 5’-Amino-5’-Deoxyribonucleosides
por: Kotkowiak, Weronika, et al.
Publicado: (2016)